HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silvio De Flora Selected Research

Chemoprevention

1/2020Modulation of smoke-induced DNA and microRNA alterations in mouse lung by licofelone, a triple COX-1, COX-2 and 5-LOX inhibitor.
12/2015Modulation by aspirin and naproxen of nucleotide alterations and tumors in the lung of mice exposed to environmental cigarette smoke since birth.
1/2015Modulation by licofelone and celecoxib of experimentally induced cancer and preneoplastic lesions in mice exposed to cigarette smoke.
1/2014Rationale and approaches to the prevention of smoking-related diseases: overview of recent studies on chemoprevention of smoking-induced tumors in rodent models.
1/2013Chemoprevention of doxorubicin-induced alopecia in mice by dietary administration of L-cystine and vitamin B6.
10/2012MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis.
3/2010Prevention of cigarette smoke-induced lung tumors in mice by budesonide, phenethyl isothiocyanate, and N-acetylcysteine.
1/2010Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.
6/2007Chemoprevention of smoke-induced alopecia in mice by oral administration of L-cystine and vitamin B6.
7/2006Development of novel cancer chemopreventive agents in Europe--neglected Cinderella or rising phoenix? A critical commentary. ESF Workshop on Cancer Chemoprevention, DKFZ, Heidelberg, September 18-20, 2005.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Silvio De Flora Research Topics

Disease

55Neoplasms (Cancer)
01/2020 - 01/2002
27Carcinogenesis
01/2018 - 04/2002
12Inflammation (Inflammations)
01/2020 - 10/2004
10Adenoma (Adenomas)
01/2018 - 12/2008
10Lung Neoplasms (Lung Cancer)
12/2016 - 02/2003
7Body Weight (Weight, Body)
01/2020 - 04/2002
4Emphysema
12/2016 - 06/2003
4Hyperplasia
12/2016 - 01/2013
4Alopecia (Baldness)
01/2013 - 05/2006
3Breast Neoplasms (Breast Cancer)
01/2018 - 12/2005
3Lung Diseases (Lung Disease)
12/2016 - 09/2009
3Carcinoma (Carcinomatosis)
12/2011 - 03/2005
3Glaucoma
01/2006 - 01/2003
2Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2015 - 06/2011
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2015 - 10/2011
2Cardiovascular Diseases (Cardiovascular Disease)
03/2011 - 09/2008
2Chronic Obstructive Pulmonary Disease (COPD)
03/2011 - 07/2009
1COVID-19
10/2020
1Human Influenza (Influenza)
10/2020
1Papilloma (Papillomatosis)
01/2018
1Adenocarcinoma
12/2015
1Hepatocellular Carcinoma (Hepatoma)
07/2015
1Infections
07/2015
1HIV Infections (HIV Infection)
07/2015
1Pulmonary Emphysema
01/2015
1Chronic Disease (Chronic Diseases)
01/2014
1Neoplasm Metastasis (Metastasis)
12/2012
1Pneumonia (Pneumonitis)
12/2011
1Virus Diseases (Viral Diseases)
07/2011
1Communicable Diseases (Infectious Diseases)
06/2011

Drug/Important Bio-Agent (IBA)

34SmokeIBA
01/2020 - 02/2002
14MicroRNAs (MicroRNA)IBA
01/2020 - 03/2009
10DNA (Deoxyribonucleic Acid)IBA
06/2014 - 01/2003
9Acetylcysteine (Siran)FDA LinkGeneric
10/2020 - 01/2002
8Biomarkers (Surrogate Marker)IBA
12/2016 - 02/2002
7AntioxidantsIBA
10/2020 - 03/2005
7CarcinogensIBA
01/2020 - 12/2005
6Estrogens (Estrogen)FDA Link
01/2018 - 07/2011
6chromium hexavalent ionIBA
01/2016 - 04/2002
6Proteins (Proteins, Gene)FDA Link
01/2015 - 10/2004
5Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2020 - 01/2015
5Pharmaceutical PreparationsIBA
01/2020 - 10/2004
4DNA AdductsIBA
01/2020 - 08/2007
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2018 - 10/2004
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2018 - 12/2015
4Complex MixturesIBA
06/2014 - 02/2003
4ProteomeIBA
10/2013 - 12/2005
4Glutathione (Reduced Glutathione)IBA
03/2010 - 04/2002
38-Hydroxy-2'-DeoxyguanosineIBA
01/2020 - 06/2003
3NucleotidesIBA
01/2020 - 01/2003
3Naproxen (Naprosyn)FDA LinkGeneric
10/2017 - 12/2015
3salicylhydroxamic acid (SHAM)IBA
01/2013 - 12/2008
3phenethyl isothiocyanate (PEITC)IBA
05/2010 - 06/2009
3Budesonide (Pulmicort)FDA LinkGeneric
03/2010 - 05/2006
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2020 - 01/2015
2licofeloneIBA
01/2020 - 01/2015
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2020 - 10/2017
2Celecoxib (Celebrex)FDA Link
09/2018 - 01/2015
2Ethanol (Ethyl Alcohol)IBA
12/2016 - 01/2016
2Tyrosine Kinase InhibitorsIBA
10/2014 - 01/2010
2Vitamin B 6IBA
01/2013 - 06/2007
2Cystine (L-Cystine)IBA
01/2013 - 06/2007
2Drinking WaterIBA
09/2009 - 11/2006
2HalogensIBA
12/2008 - 03/2005
2Reactive Oxygen Species (Oxygen Radicals)IBA
08/2007 - 01/2006
2MutagensIBA
08/2007 - 12/2005
2sodium bichromate (sodium dichromate)IBA
11/2006 - 04/2002
1CytosineIBA
01/2020
1Histones (Histone)IBA
01/2020
14- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA
01/2020
1LipopolysaccharidesIBA
01/2020
1Cyclooxygenase 1IBA
12/2015
1Transcription Factor 4IBA
12/2015
1VaccinesIBA
07/2015
1Antiviral Agents (Antivirals)IBA
07/2015
1Combined VaccinesIBA
07/2015
1Amyloid (Amyloid Fibrils)IBA
01/2015
1Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
01/2015
1Lapatinib (GW572016)FDA Link
10/2014
1ErbB Receptors (EGF Receptor)IBA
10/2014
1human ERBB2 proteinIBA
10/2014
1Metformin (Glucophage)FDA LinkGeneric
06/2014
1Bexarotene (LGD1069)FDA Link
10/2013
1Pioglitazone (Actos)FDA Link
10/2013
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2013
1VorinostatFDA Link
01/2013
1Gonadal Steroid Hormones (Sex Hormones)IBA
01/2013
1Histone Deacetylase InhibitorsIBA
01/2013
1Oxidants (Oxidizing Agents)IBA
10/2011
1Biological ProductsIBA
07/2011
1Particulate MatterIBA
03/2011
1Coal AshIBA
03/2011
1Estrogen Receptor betaIBA
03/2010
1Monoclonal AntibodiesIBA
01/2010

Therapy/Procedure

16Chemoprevention
01/2020 - 01/2004
7Oral Administration
10/2020 - 04/2002
5Therapeutics
10/2020 - 12/2005
3Secondary Prevention
12/2016 - 12/2005
2Drug Therapy (Chemotherapy)
01/2013 - 01/2010
2Tertiary Prevention
06/2011 - 12/2005